Plethora Solutions Holdings PLC (”Plethora” or the “Company”, AIM: PLE), the specialist developer of products for the treatment and management of urological disorders, announces that its European Phase III double-blind placebo controlled study of PSD502 for the treatment of premature ejaculation (PE) has met its three co-primary endpoints of Intra-vaginal Ejaculation Latency Time (’IELT’) and [...]
More...
Selcuk University Meram medical School, Urology Department, 42080 Konya, Turkey. (Source: UroToday)
MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.
ED news: Temporary cavernosal-cephalic vein shunt in low-flow priapism treatment - abstract
Watch medical videos about ED and other impotence related material and read news about erectile [...]
More...
A study among Baltimore inner-city teenage girls treated for pelvic inflammatory disease shows they are highly vulnerable to subsequent sexually transmitted infections (STI) - sometimes within a few weeks or months of their treatment.
Diagnosis Of Pelvic Inflammatory Disease Predicts High Risk And High Rate Of Further Infection In Teenagers
Watch medical videos about STD and other [...]
More...
What is erectile dysfunction, and what treatment options are available?
ED news: Erectile Dysfunction
Watch medical videos about ED and other impotence related material and read news about erectile dysfunction and impotence remedies here at Viagra Video!
More...
